Diabetes distress: practical considerations Read more about Diabetes distress: practical considerations
Inpatient Diabetes in the 21st Century: CSI or CSII Read more about Inpatient Diabetes in the 21st Century: CSI or CSII
A deep dive into the semaglutide (Ozempic ) SUSTAIN programme Read more about A deep dive into the semaglutide (Ozempic ) SUSTAIN programme
Proinsulin peptide C19-A3 immunotherapy in new-onset type 1 diabetes is well-tolerated and associated with reduced total daily insulin usage Read more about Proinsulin peptide C19-A3 immunotherapy in new-onset type 1 diabetes is well-tolerated and associated with reduced total daily insulin usage
Prevalence of risk factors and burden of diabetic foot disease amongst patients on haemodialysis Read more about Prevalence of risk factors and burden of diabetic foot disease amongst patients on haemodialysis
Wide variation in the per patient cost of prescribing of diabetes drugs for type 2 diabetes in primary care is not correlated with metabolic outcome Read more about Wide variation in the per patient cost of prescribing of diabetes drugs for type 2 diabetes in primary care is not correlated with metabolic outcome
Is electronic referral system an answer for better coordinated inpatient diabetes care? Read more about Is electronic referral system an answer for better coordinated inpatient diabetes care?
